PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 22 filers reported holding PHARVARIS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $116 | -100.0% | 10,286 | -90.7% | 0.00% | -100.0% |
| Q3 2022 | $889,000 | -50.9% | 110,666 | +35.0% | 0.00% | 0.0% |
| Q2 2022 | $1,811,000 | -10.7% | 81,954 | -24.4% | 0.00% | 0.0% |
| Q1 2022 | $2,027,000 | +7.2% | 108,386 | -9.3% | 0.00% | 0.0% |
| Q4 2021 | $1,891,000 | -30.5% | 119,558 | -24.2% | 0.00% | -50.0% |
| Q3 2021 | $2,721,000 | -24.0% | 157,753 | -19.9% | 0.00% | 0.0% |
| Q2 2021 | $3,579,000 | -44.8% | 196,967 | -14.7% | 0.00% | -60.0% |
| Q1 2021 | $6,479,000 | – | 230,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,246,926 | $26,153,989 | 13.57% |
| venBio Partners LLC | 2,278,575 | $18,353,922 | 10.17% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $25,620 | 3.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 559,387 | $4,505,862 | 1.86% |
| 5AM Venture Management, LLC | 587,600 | $4,733,118 | 1.21% |
| Sio Capital Management, LLC | 228,385 | $1,839,641 | 0.91% |
| Novo Holdings A/S | 1,329,325 | $10,714,360 | 0.71% |
| Cormorant Asset Management, LP | 816,460 | $6,577 | 0.43% |
| Soleus Capital Management, L.P. | 336,900 | $2,713,730 | 0.28% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $19,494,349 | 0.23% |